United Therapeutics | UTHR - القيمة السوقية





القيمة السوقية تغيير تاريخ
Amarin USD 290M 51M 2025-12
Ardelyx USD 1.48B 63M 2026-03
Baxter International USD 11.01B 2.34B 2026-06
Bayer EUR 48.39B 834.21M 2026-08
BioCryst Pharmaceuticals USD 1.9B 643M 2026-08
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Emergent BioSolutions USD 125M 51M 2023-12
Gilead Sciences USD 168.68B 11.82B 2026-08
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Halozyme Therapeutics USD 10.91B 1.63B 2026-08
Insmed USD 19.68B 3.43B 2026-08
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 611.36B 32.21B 2026-06
Lexicon Pharmaceuticals USD 418M 73M 2025-12
Pfizer USD 153.17B 14.73B 2026-08
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Sarepta Therapeutics USD 1.5B 402M 2026-08
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
United Therapeutics USD 24.42B 1.42B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08